The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Metastasis-directed treatment (MDT) for patients (pts) with non-clear cell renal cell carcinoma (nccRCC): Results from a matched 15-year retrospective cohort.
 
Rogerio Almeida Moreno Santos
No Relationships to Disclose
 
Gabriel Polho
Travel, Accommodations, Expenses - Libbs
 
Vinicius Parrela
No Relationships to Disclose
 
Matheus Arneiro
No Relationships to Disclose
 
Matheus Andrade
No Relationships to Disclose
 
Gustavo Alves Contado
No Relationships to Disclose
 
Douglas Tozzo Machado Ferreira
No Relationships to Disclose
 
Vitor Felix
No Relationships to Disclose
 
Letícia Murazawa
No Relationships to Disclose
 
Luisa Costa
No Relationships to Disclose
 
Nathália Crusoé
No Relationships to Disclose
 
Jose Mauricio Mota
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Bayer; Ipsen; Janssen; Merck; Novartis; Pfizer; Zodiac Pharma
Consulting or Advisory Role - Astellas Pharma; Janssen Oncology
Speakers' Bureau - Amgen; Astellas Pharma; AstraZeneca; Bayer; Ipsen; Janssen Oncology; Merck; Novartis; Pfizer; Zodiac Pharma
Research Funding - Bayer
Expert Testimony - Adium Pharma; Astellas Pharma; Bayer
Travel, Accommodations, Expenses - Janssen Oncology; Zodiac Pharma